Food Safety Incidents

Adverse effects tachycardia and shortness of breath has been detected in Dietary supplement shapezinh the.

Written by SGS Digicomply Editorial Team | Feb 27, 2026 11:00:00 PM

Food Safety Incident Report

Date: February 12, 2026

A recent incident has been reported concerning a dietary supplement that has been linked to adverse health effects. Individuals consuming this product have experienced symptoms such as tachycardia (rapid heartbeat) and shortness of breath. These symptoms raise significant concerns regarding the safety and quality of the dietary supplement in question.

The product, described as a dietary supplement, originates from Brazil and has been flagged by the Brazilian Health Regulatory Agency (ANVISA) for control. The agency is responsible for ensuring the safety and efficacy of food and health products within the country, and their involvement indicates a serious potential risk to consumers.

Consumers are advised to exercise caution and refrain from using this dietary supplement until further information is provided by health authorities. It is crucial to monitor any health changes and seek medical attention if experiencing similar symptoms after consumption.

Regulatory agencies typically conduct thorough investigations in such cases to determine the root cause of the adverse effects and to ensure that appropriate measures are taken to protect public health. This incident highlights the importance of vigilance when it comes to dietary supplements and reinforces the need for consumers to be informed about the products they choose to consume.

  • Incident: Adverse effects tachycardia and shortness of breath has been detected in Dietary supplement shapezinh the.
  • Date: 2026-02-12
  • Product: Dietary supplement shapezinh the
  • Market: Available to SGS Digicomply users only. Explore the platform (for enterprises, no individual plans)
  • Origin of issue: Brazil
  • Hazard: Available to SGS Digicomply users only. Explore the platform (for enterprises, no individual plans)
  • Incident Category: Control
  • Source: Brazilian Health Regulatory Agency - ANVISA